1-2 of 2
Aoshuang Xu
Close
Sort by
Journal Articles

Class Ⅱ ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma

Jiasi Zhang, Yuxi Liu, Liping Zuo, Fengjuan Fan, Han Yan, Fei Zhao, Junying Li, Chi Ma, Qun Li, Aoshuang Xu, Jian Xu, Bo Zhang, Yu Hu, Chunyan Sun
Journal: Blood Advances
Blood Adv bloodadvances.2023010335.
https://doi.org/10.1182/bloodadvances.2023010335
Published: 2024
Includes: Supplemental data
Journal Articles

Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome

Clinical Trials & Observations
Chunyan Sun, Jian Xu, Bo Zhang, Haifan Huang, Lei Chen, Han Yan, Aoshuang Xu, Fei Zhao, Daijuan Huang, Liqiong Liu, Jian Li, Yu Hu
Journal: Blood Advances
Blood Adv (2021) 5 (12): 2563–2568.
https://doi.org/10.1182/bloodadvances.2020003783
Published: 2021
Includes: Supplemental data